MC

498.85

-0.03%↓

NDA.FI

11.79

+0.94%↑

DIM

201.7

+0.35%↑

MC

498.85

-0.03%↓

NDA.FI

11.79

+0.94%↑

DIM

201.7

+0.35%↑

MC

498.85

-0.03%↓

NDA.FI

11.79

+0.94%↑

DIM

201.7

+0.35%↑

MC

498.85

-0.03%↓

NDA.FI

11.79

+0.94%↑

DIM

201.7

+0.35%↑

MC

498.85

-0.03%↓

NDA.FI

11.79

+0.94%↑

DIM

201.7

+0.35%↑

Search

AB Science SA

Fermé

1.428 -2.19

Résumé

Variation du prix de l'action

24h

Actuel

Min

1.428

Max

1.428

Chiffres clés

By Trading Economics

Revenu

-4.5M

Ventes

560K

Marge bénéficiaire

-798.036

Employés

40

EBITDA

-4.6M

Dividendes

By Dow Jones

Prochains Résultats

29 avr. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

93M

Ouverture précédente

3.62

Clôture précédente

1.428

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

AB Science SA Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

25 avr. 2025, 17:01 UTC

Résultats
Principaux Mouvements du Marché

Aon Shares Sink After 1Q Profit Falls, Sales Miss Estimates

25 avr. 2025, 16:10 UTC

Résultats
Principaux Mouvements du Marché

Coursera Shares Rise After 1Q Beat, Better-Than-Expected Revenue View

26 avr. 2025, 18:14 UTC

Résultats

Tech Executives Are Starting to Talk Tariffs. What It May Mean for Apple, Amazon Earnings -- Barrons.com

26 avr. 2025, 15:00 UTC

Résultats
Acquisitions, Fusions, Rachats

Trump 2.0 Era Brings Flurry of Crypto Deals -- WSJ

26 avr. 2025, 08:20 UTC

Market Talk
Résultats

Tech, Media & Telecom Roundup: Market Talk

25 avr. 2025, 21:24 UTC

Actualités

Cargo Shipments From China to the U.S. Dwindle -- WSJ

25 avr. 2025, 20:50 UTC

Market Talk
Résultats

Tech, Media & Telecom Roundup: Market Talk

25 avr. 2025, 20:45 UTC

Actualités

Stocks Claw Back Most of April's Tariff Losses -- WSJ

25 avr. 2025, 20:39 UTC

Résultats

The Score: Tesla, Capital One, Boeing and More Stocks That Defined the Week -- WSJ

25 avr. 2025, 20:37 UTC

Actualités

Trump Administration Lays Out Tariff Roadmap to Streamline Trade Talks -- WSJ

25 avr. 2025, 20:19 UTC

Actualités

Nasdaq Climbs More Than 1% as Stocks Finish Strong Week -- WSJ

25 avr. 2025, 20:15 UTC

Résultats

Week's Best: A Dividend Expert's Best Advice -- Barrons.com

25 avr. 2025, 19:23 UTC

Market Talk

U.S. Natural Gas Futures Extend Weekly Losses -- Market Talk

25 avr. 2025, 19:18 UTC

Market Talk

Oil Futures End Choppy Week With Losses -- Market Talk

25 avr. 2025, 18:47 UTC

Market Talk

Gold Extends Pullback to Close Week -- Market Talk

25 avr. 2025, 18:39 UTC

Actualités

Nasdaq, Dow Industrials About Flat; Analysts Caution on Trump Tariffs -- WSJ

25 avr. 2025, 18:34 UTC

Acquisitions, Fusions, Rachats

Goldman Sachs Upgrades Schwab Stock. Here's Why. -- Barrons.com

25 avr. 2025, 18:32 UTC

Market Talk
Résultats

Global Equities Roundup: Market Talk

25 avr. 2025, 18:32 UTC

Market Talk
Résultats

Carriers See Tariffs Driving Up Phone Prices, Slowing Upgrades -- Market Talk

25 avr. 2025, 18:08 UTC

Résultats

Sphere Entertainment Deal Is a Win for Shareholders as Banks Take a Hit -- Barrons.com

25 avr. 2025, 17:55 UTC

Market Talk

U.S. Oil Rig Count Rises By 2 to 483 -- Market Talk

25 avr. 2025, 17:40 UTC

Actualités

Consumers Continue to Sour on the Economy -- 4th Update

25 avr. 2025, 17:38 UTC

Résultats

Centene Stock Falls on Medicaid Cost Worries -- Barrons.com

25 avr. 2025, 17:07 UTC

Market Talk

Oil Futures Turn Higher in Quiet Trade -- Market Talk

25 avr. 2025, 16:54 UTC

Market Talk
Résultats

Mobile Carriers See Stronger Activity on Bigger Price Tags, Tariffs -- Market Talk

25 avr. 2025, 16:46 UTC

Résultats

Reddit, Meta, and Pinterest Stocks Rise. How Alphabet's Earnings Are Giving Them a Boost. -- Barrons.com

25 avr. 2025, 16:20 UTC

Market Talk
Résultats

Basic Materials Roundup: Market Talk

25 avr. 2025, 16:12 UTC

Actualités

Dow Industrials Fall; China Plans Economic Support During Trade Battle -- WSJ

25 avr. 2025, 16:03 UTC

Résultats

AbbVie Stock Rises Despite Risks as Earnings Beat Forecasts -- Barrons.com

25 avr. 2025, 15:52 UTC

Market Talk

Grains Mixed on Low Volume Trade -- Market Talk

Comparaison

Variation de prix

AB Science SA prévision

Score Technique

By Trading Central

1.34 / 1.46Support & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Bullish Evidence

Long Terme

Bullish Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos AB Science SA

AB Science S.A., a clinical-stage company, designs and develops novel drugs to various diseases with high unmet medical needs for inflammatory diseases, pathologies affecting peripheral and central nervous system, and cancers in France. The company's lead compound is the masitinib, a tyrosine kinase inhibitor which is in Phase III clinical trials for the treatment of amyotrophic lateral sclerosis, indolent systemic mastocytosis, severe asthma, progressive forms of multiple sclerosis, first line pancreatic cancer with pain, alzheimer's disease, and metastatic castrate-resistant prostate cancer, as well as in Phase II clinical trial to treat Covid-19. It also developing AB8939, a microtubule destabiliser for acute myeloid leukemia. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.